Xtl Biopharmaceuticals Ltd Nasdaq Xtlbtase Xtlb Tais A Clinical Stage Biotech Company Focused On The Development Of Pharmaceutical Products For The Treatment Of Autoimmune Diseases Including Lupus The Company S Lead Drug Candidatehcdr1Is A World Class Clinical Asset For The Treatment Of Systemic Lupus Erythematosussle Treatments Currently On The Market For Sle Are Not Effective Enough For Most Patients And Some Have Significant Side Effectsrobust Clinical Data On Hcdr1 Has Been Produced In Three Clinical Trials With 400 Patients And Over 200 Preclinical Studies With Data Published In More Than 40 Peer Reviewed Scientific Journals
No conferences found for this company.
| Company Name | Xtl Biopharmaceuticals Ltd |
| Country |
Israel
|
| Address | N/A |
| Telephone | N/A |
| N/A |
